亨廷顿国家银行将其持有的 Incyte 增加了 40.7%，而一名高管出售了 19,807 股股票。 Huntington National Bank boosted its Incyte holdings by 40.7%, while an exec sold 19,807 shares.

Huntington国家银行在第四季度将生物制药公司Incyte Corp.的股份增加了40.7%,购买了270多股,共计934股。 Huntington National Bank increased its holdings in biopharmaceutical company Incyte Corp. by 40.7% in the fourth quarter, purchasing 270 more shares for a total of 934. 同时,机构投资者聚氨酯资本管理美国有限责任公司投资于Incyte,获得4 798份股份。 Meanwhile, institutional investor Polymer Capital Management US LLC invested in Incyte, acquiring 4,798 shares. 然而,一些高管最近出售了股票,Barry P. Flannelly出售了19 807股股票。 However, some executives sold shares recently, with Barry P. Flannelly selling 19,807 shares. 尽管缺少收入估计数,分析人员预计Incyte今年每股收入为4.86美元,评级为“延迟”,价格目标为74.88美元。 Despite missing earnings estimates, analysts expect Incyte to post 4.86 earnings per share this year, with a "Hold" rating and a price target of $74.88.